FDA Clearance Tracker · K250419
Intimate Rose Pelvic Wand (Purple); Intimate Rose Bendable Pelvic Wand (Orange); Intimate Rose Temperature Pelvic Wand (Yellow)
Last checked: Nov 20, 2026Latest source record: Jul 27, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Jul 27, 2026
Substantially Equivalent
Time to decision
529 days
Received Feb 13, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K250419
- Device name
- Intimate Rose Pelvic Wand (Purple); Intimate Rose Bendable Pelvic Wand (Orange); Intimate Rose Temperature Pelvic Wand (Yellow)
- Applicant location
- North Kansas City, MO
- Received
- Feb 13, 2025
- Decided
- Jul 27, 2026
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Massager, Therapeutic, To Internally Massage Trigger Points In The Pelvic Floor Musculature (OSD)
- Device class
- Class II
- Regulation
- 21 CFR 890.5670
- Specialty
- Physical Medicine & Rehabilitation
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code OSD. The earliest in FDA's data is DEN100023, decided Nov 20, 2012.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K250419
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Plus EV Holdings, Inc. D/B/A Intimate Rose
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.